Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologyKaiser Permanente MPI Coverage Update | OpenPayer
    Ask Trek AI about this page
    CurrentKaiser PermanentePolicy N/A

    Myocardial Perfusion Imaging (Exercise and Pharmacologic Nuclear Stress Tests) — Clinical Review Criteria

    Customize your policy alerts

    Sign up for all Kaiser Permanente policy alerts

    Know when Kaiser Permanente releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Clinical review criteria governing medical necessity review and preauthorization guidance for myocardial perfusion imaging (exercise and pharmacologic nuclear stress tests) for Kaiser Foundation Health Plan of Washington members and providers.

    Policy Summary
    PayerKaiser Permanente
    PolicyMyocardial Perfusion Imaging (Exercise and Pharmacologic Nuclear Stress Tests) — Clinical Review Criteria
    Policy CodePolicy N/A
    Change TypeMedical necessity review initiatedcoding and criteria clarified
    Effective DateN/A
    Last ReviewJan 5, 2021
    Next Review DateN/A
    Key ActionObtain and submit the last 6 months of clinical notes to support medical necessity for MPI prior authorization.
    SourceLink
    POLICY UPDATE CHANGES

    Initiated medical necessity review of MPI for Medicare Advantage members to align with 2024 CMS final rule, effective February 1, 2024.

    Updated applicable CPT codes and coding guidance for myocardial perfusion imaging.

    Updated hybrid criteria to improve performance of the MPI 2024 criteria.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    78451-78454
    Primary CPT codes listed for MPI
    20%Estimated contribution to annual radiation dose
    MCG usedNon-Medicare criteria source
    Feb 1, 2024Medicare review started

    Coverage and Medical Necessity Criteria

    Medicare and Non-Medicare Medical Necessity Determination

    MPI is considered medically necessary when criteria in the applicable policy statements or referenced MCG guidelines are met.

    Medicare Members: Medicare members: CMS/NCDs none specified; local LCD and LCA apply (Cardiovascular Stress Testing including Exercise and/or Pharmacological Stress and Stress Echocardiography L36889 and Billing/Coding article A57184). Medical necessity is met when the applicable policy statements are satisfied.

    Reference local coverage determinations/articles for Medicare reviews.

    Non-Medicare Members: Non-Medicare members: Kaiser Permanente uses MCG Myocardial Perfusion Imaging guidelines for Exercise Stress (KP-0078) and Pharmacologic Stress (KP-0079) to determine medical necessity.

    Access to MCG criteria via provider portal; proprietary MCG content not reproduced here.

    Pharmacologic vasodilator stress agents adenosine and dipyridamole are contraindicated in patients with severe reactive airway disease (for example, asthma or chronic obstructive pulmonary disease) because they may provoke bronchospasm; in these patients, consider substitution with regadenoson or dobutamine. This contraindication applies specifically to pharmacologic myocardial perfusion stress testing when vasodilators would otherwise be used.

    When CPT codes for myocardial perfusion imaging (for example, 78451–78454) are submitted, medical necessity is not met if the services do not satisfy the applicable policy criteria or referenced MCG guideline criteria. Claims for these codes that lack documentation or clinical justification meeting the policy standards are subject to denial for lack of medical necessity.

    Applicable Codes

    Applicable CPT CodesCPTCovered
    78451Myocardial perfusion imaging; tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional
    78452Myocardial perfusion imaging; tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic).
    78453Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or technique, additional quantification, when performed); single study, at rest or stress (exercise or pharmacologic) gated.
    78454Myocardial perfusion imaging; planar (including qualitative or quantitative wall motion, ejection fraction by first pass or technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection gated.

    Provider Actions, Prior Authorization, and Documentation

    Prior Authorization

    Obtain prior authorization / medical necessity review for MPI CPT codes

    Medical necessity review (prior authorization) is required for the listed myocardial perfusion imaging CPT codes (78451, 78452, 78453, 78454) when applicable; Medicare Advantage members are subject to initiated medical necessity review effective February 1, 2024. To verify authorization requirements for a specific code by plan type, use the Pre-authorization Code Check.

    • Applicable CPT codes: 78451, 78452, 78453, 78454
    • Medicare Advantage medical necessity review initiated to align with 2024 CMS final rule, effective Feb 1, 2024
    Step Therapy

    Step therapy: none specified; use MCG for non‑Medicare

    No step therapy program is specified in this policy. For non‑Medicare members, Kaiser Permanente uses MCG Myocardial Perfusion Imaging guidelines for exercise (KP-0078) and pharmacologic (KP-0079) MPI to determine medical necessity.

    • No insurer-directed step edits listed in this policy

    Background

    Myocardial perfusion imaging (MPI), commonly performed as exercise or pharmacologic stress SPECT, uses intravenous radiotracers (eg, thallium, sestamibi, tetrofosmin) taken up by myocardial cells and imaged with a gamma camera to reflect regional blood perfusion. Stress is produced by exercise or by pharmacologic agents (vasodilators such as adenosine, dipyridamole, regadenoson, or an adrenergic agent such as dobutamine) to unmask perfusion defects that may indicate ischemia. When synchronized with the ECG (eg, gated SPECT), MPI also provides assessment of ventricular function, including ejection fraction. The policy lists applicable CPT codes for these procedures (eg, 78451–78454) and applies medical necessity criteria for Medicare and non‑Medicare members as described in the policy and referenced MCG guidance.

    Definitions

    Gated SPECT / Myocardial perfusion imaging (MPI)
    DefinitionNuclear myocardial perfusion imaging (eg, tomographic SPECT) using intravenous radiotracers (eg, thallium, sestamibi, tetrofosmin) to visualize myocardial blood perfusion; when synchronized with ECG (gated SPECT) it also assesses ventricular function including ejection fraction.
    PurposeDetects areas of ischemia when stress images show defects not present at rest and provides management and prognostic information for patients at intermediate risk for coronary artery disease.
    Technique notesUses digital gamma cameras; can be combined with CT in hybrid SPECT/CT systems to improve localization and attenuation correction.
    Clinical utilityMost useful for patients at intermediate CAD risk, those needing management/prognostic data, and those with unexplained persistent symptoms.
    Radiation considerationMyocardial perfusion scans account for an estimated ≥20% of the annual collective radiation dose in the U.S.; lifetime cancer risk from a single study is thought to be small.
    Policy Summary
    PayerKaiser Permanente
    PolicyMyocardial Perfusion Imaging (Exercise and Pharmacologic Nuclear Stress Tests) — Clinical Review Criteria
    Policy CodePolicy N/A
    Change TypeMedical necessity review initiatedcoding and criteria clarified
    Effective DateN/A
    Last ReviewJan 5, 2021
    Next Review DateN/A
    Key ActionObtain and submit the last 6 months of clinical notes to support medical necessity for MPI prior authorization.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaApplicable CodesProvider Actions, Prior Authorization, and DocumentationBackgroundDefinitions
  1. Non‑Medicare determinations follow MCG criteria (access via provider portal)
  2. Documentation Required

    Provide last 6 months of clinical notes

    Include the last 6 months of clinical notes from the requesting provider and/or specialist with the request to support medical necessity.

    • Submit recent clinic notes documenting symptoms, prior testing, and rationale for MPI
    • Attach specialist consult notes when applicable
    Denial Risk

    Coding-based denial risk for MPI CPTs

    Claims for myocardial perfusion imaging may be denied if the submitted CPT codes (78451–78454) do not meet the applicable policy or MCG medical necessity criteria.

    • Ensure documentation and clinical indications meet the policy/MCG criteria before billing these CPT codes
    Documentation Required

    Document submission missing may trigger denial

    Failure to provide required documentation — for example, the last 6 months of clinical notes — may result in denial of medical necessity for the requested MPI service.

    • Include requested notes with prior authorization submission to avoid delays or denials
    Pharmacologic stress agents
    DefinitionPharmacologic stress agents are vasodilators (adenosine, dipyridamole, regadenoson) or an adrenergic agent (dobutamine) used to induce coronary hyperemia when exercise is not feasible or in addition to submaximal exercise.
    Common vasodilatorsAdenosine, dipyridamole, regadenoson (used to induce coronary hyperemia for pharmacologic stress SPECT).
    Adrenergic agentDobutamine (used as an alternative pharmacologic stressor when vasodilators are not appropriate).
    Contraindication noteAdenosine and dipyridamole are contraindicated in patients with severe reactive airway disease (eg, asthma or COPD); regadenoson or dobutamine may be substituted in this population.